{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:34:26Z","timestamp":1767864866145,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jemermed.2022.07.014","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T08:30:40Z","timestamp":1665477040000},"page":"467-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["What is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response?"],"prefix":"10.1016","volume":"63","author":[{"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-9095","authenticated-orcid":false,"given":"Samuel M.","family":"Keim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian G.","family":"Stiell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2022.07.014_bib0001","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.amjcard.2017.08.017","article-title":"Emergency department, hospital inpatient, and mortality burden of atrial fibrillation in the United States, 2006 to 2014","volume":"120","author":"Jackson","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MEJ.0000000000000227","article-title":"Beta-blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review","volume":"22","author":"Martindale","year":"2015","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0003","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan","year":"2005","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0005","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","volume":"16","author":"January","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0006","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.annemergmed.2013.06.005","article-title":"A population-based description of atrial fibrillation in the emergency department, 2002 to 2010","volume":"62","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications","volume":"37","author":"Chugh","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0008","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994\u20131998: analysis of data from the general practice research database","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0011","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0012","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15420\/aer.2021.07","article-title":"The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation","volume":"10","author":"Kotalczyk","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0014","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0015","first-page":"1114","article-title":"2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"30","author":"Verma","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0016","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajem.2018.01.066","article-title":"Emergency medicine considerations in atrial fibrillation","volume":"36","author":"Long","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ehj.2014.03.004","article-title":"Update on atrial fibrillation","volume":"66","author":"Shenasa","year":"2014","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0018","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2014.09.012","article-title":"Emergency department patients with atrial fibrillation or flutter and an acute underlying medical illness may not benefit from attempts to control rate or rhythm","volume":"65","author":"Scheuermeyer","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0019","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.annemergmed.2014.12.010","article-title":"Managing atrial fibrillation","volume":"65","author":"Atzema","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/acem.12091","article-title":"Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness","volume":"20","author":"Scheuermeyer","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0021","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajem.2020.11.039","article-title":"Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department","volume":"46","author":"McGrath","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajem.2020.11.073","article-title":"Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem","volume":"40","author":"Hargrove","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0023","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2146\/ajhp160126","article-title":"Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department","volume":"73","author":"Hines","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0024","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajem.2020.06.034","article-title":"Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control","volume":"38","author":"Nicholson","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211017756","article-title":"Rate control with intravenous diltiazem, verapamil, and metoprolol in acute atrial fibrillation with rapid ventricular rate","volume":"9","author":"Medeiros","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0026","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0027","series-title":"Diltiazem hydrochloride [package insert]","year":"2007"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0028","series-title":"Metoprolol tartrate [package insert]","year":"2008"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0029","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9149(90)90351-Z","article-title":"Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II\u2013DAVIT II)","volume":"66","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0030","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0031","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0032","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajem.2018.04.062","article-title":"Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction","volume":"37","author":"Hirschy","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0034","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1001\/jama.1983.03330420058038","article-title":"The use of beta-blockers after myocardial infarction","volume":"249","author":"Turi","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0035","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0036","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0037","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s43678-021-00167-y","article-title":"2021 CAEP Acute Atrial Fibrillation\/Flutter Best Practices Checklist","volume":"23","author":"Stiell","year":"2021","journal-title":"CJEM"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0038","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(19)32994-0","article-title":"Electrical vs. pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial","volume":"395","author":"Stiell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2022.07.014_bib0039","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s43678-021-00116-9","article-title":"Just the facts: atrial fibrillation or flutter in patients who are candidates for rate control","volume":"23","author":"Scheuermeyer","year":"2021","journal-title":"CJEM"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467922004346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467922004346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:41Z","timestamp":1760028581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467922004346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0736467922004346"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2022.07.014","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the Best Agent for Rate Control of Atrial Fibrillation With Rapid Ventricular Response?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2022.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}